During the past decade, Pulmonary Arterial Hypertension Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Pulmonary Arterial Hypertension Clinic" are "Chronic Thromboembolic Pulmonary Hypertension" (1 trials) and "Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)" (1 trials). Many other conditions were trialed in "Pulmonary Arterial Hypertension Clinic" in a lesser frequency.

Most popular intervention types in "Pulmonary Arterial Hypertension Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "FDC macitentan/tadalafil" (1 trials), "Macitentan 10 mg" (1 trials), "Placebo" (1 trials), "Placebo FDC" (1 trials) and "Placebo macitentan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pulmonary Arterial Hypertension Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Pulmonary Arterial Hypertension Clinic". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Pulmonary Arterial Hypertension Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pulmonary Arterial Hypertension Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".